Related Experiment Video

Updated: May 2, 2026

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis
09:45

Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis

Published on: March 31, 2015

10.9K

Inactivation of SMC2 shows a synergistic lethal response in MYCN-amplified neuroblastoma cells

Yuko Murakami-Tonami1, Satoshi Kishida1, Ichiro Takeuchi2

  • 1Department of Molecular Biology; Nagoya University Graduate School of Medicine; Nagoya, Japan.

Cell Cycle (Georgetown, Tex.)
|February 21, 2014
PubMed

Insights

MYCN amplifies the SMC2 gene in neuroblastoma, impacting DNA damage and cell death. Low SMC2 expression correlates with better survival in patients with MYCN-amplified tumors, suggesting SMC2 as a therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • The condensin complex is crucial for mitosis but its interphase role is unknown.
  • Neuroblastoma, a common childhood cancer, often has poor prognosis linked to MYCN gene amplification.
  • The function of SMC2 (a condensin subunit) in neuroblastoma is not well understood.

Purpose of the Study:

  • To investigate the role of SMC2 in MYCN-amplified neuroblastoma.
  • To determine if MYCN regulates SMC2 expression.
  • To explore SMC2 as a potential therapeutic target in neuroblastoma.

Main Methods:

  • Transcriptional analysis of SMC2 in neuroblastoma cells.
  • Investigating the regulatory relationship between MYCN and SMC2.
  • Assessing the impact of SMC2 downregulation on DNA damage and apoptosis.
  • Correlating SMC2 expression with patient survival data.

Main Results:

  • MYCN directly regulates the transcription of the SMC2 gene.
  • SMC2 cooperates with MYCN to regulate DNA damage response genes.
  • SMC2 downregulation induces DNA damage and apoptosis in MYCN-amplified neuroblastoma cells.
  • Low SMC2 expression is associated with improved survival in patients with MYCN-amplified neuroblastoma.

Conclusions:

  • SMC2 plays a novel role in DNA damage response in neuroblastoma.
  • SMC2 is a downstream target of MYCN in neuroblastoma.
  • SMC2 represents a potential therapeutic target for MYCN-amplified neuroblastoma.
Keywords:
DNA damage responseMYCNcondensin complexneuroblastomasynergistic lethal response

More Related Videos

Zebrafish Model of Neuroblastoma Metastasis05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

2.5K
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

13.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
14.8K